title: Response to: laboratory assessment may be dependent on the time of liver biopsy.
authors.affiliation: Department of Gastroenterology, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: George B
authors.initials: GB
authors.lastname: Goh
authors.forename: Mangesh
authors.initials: M
authors.lastname: Pagadala
authors.forename: Jaividhya
authors.initials: J
authors.lastname: Dasarathy
authors.forename: Aynur
authors.initials: A
authors.lastname: Unalp-Arida
authors.forename: Ruth
authors.initials: R
authors.lastname: Sargent
authors.forename: Carol
authors.initials: C
authors.lastname: Hawkins
authors.forename: Achuthan
authors.initials: A
authors.lastname: Sourianarayanane
authors.forename: Amer
authors.initials: A
authors.lastname: Khiyami
authors.forename: Lisa
authors.initials: L
authors.lastname: Yerian
authors.forename: Rish
authors.initials: R
authors.lastname: Pai
authors.forename: Arthur
authors.initials: A
authors.lastname: McCullough
authors.forename: Srinivasan
authors.initials: S
authors.lastname: Dasarathy
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008099:Liver / Q000187:drug effects*; D008297:Male; D065626:Non-alcoholic Fatty Liver Disease / Q000188:drug therapy*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors